tm logo

Monitor this mark

View On USPTO

LUPUS NEPHRITIS PEER CONNECT
Live/Registered
REGISTERED

on 23 Jan 2024

Last Applicant/ Owned by

Aurinia Pharmaceuticals Inc.

1203-4464 Markham Street

Victoria, B.C.

CA

V8Z7X8

Serial Number

97468741 filed on 21st Jun 2022

Registration Number

7290297 registered on 23rd Jan 2024

in the Supplemental Register

Correspondent Address

Matthew R. Wilmot

Matthew R. Wilmot

760 SW NINTH AVENUE, SUITE 3000

PORTLAND,OR 97205

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LUPUS NEPHRITIS PEER CONNECT

Providing educational mentoring services and programs in the field of auto-immune diseases; Providing educational mentoring services and programs in the field of Lupus Nephritis

Classification Information

Class [041]
Education and Entertainment Services

Providing educational mentoring services and programs in the field of auto-immune diseases; Providing educational mentoring services and programs in the field of Lupus Nephritis

First Use Date in General

30th Nov 2022

First Use Date in Commerce

30th Nov 2022

Specimens

LUPUS NEPHRITIS PEER CONNECT specimenLUPUS NEPHRITIS PEER CONNECT specimenLUPUS NEPHRITIS PEER CONNECT specimenLUPUS NEPHRITIS PEER CONNECT specimen

Mark Details

Serial Number

No 97468741

Mark Type

No Service Mark

Attorney Docket Number

No 66570-35

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Jan 2024REGISTERED-SUPPLEMENTAL REGISTER
23rd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
12th Dec 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11th Dec 2023USE AMENDMENT ACCEPTED
11th Dec 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01st Dec 2023TEAS/EMAIL CORRESPONDENCE ENTERED
30th Nov 2023USE AMENDMENT FILED
30th Nov 2023AMENDMENT TO USE PROCESSING COMPLETE
30th Nov 2023TEAS AMENDMENT OF USE RECEIVED
30th Nov 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED